NIH promotes use of lower cost drugs for hypertension

BMJ 2004; 328 doi: (Published 04 March 2004) Cite this as: BMJ 2004;328:539
  1. David Spurgeon
  1. Quebec

    Embedded Image

    Dr Paul Whelton is worried because doctors are not implementing trial findings


    The US National Institutes of Health is planning to use some 600 prominent doctors in the United States, Canada, and Puerto Rico to promote the use of lower cost drugs to treat hypertension.

    Currently, the cost of antihypertensive drugs in the United States amounts to about $15bn (£8bn; €12bn), accounting for 10% of the country's total spending on drugs. The institutes' $3.7m initiative is the first time it has tried to promote a change in …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to to receive unlimited access to all content on for 14 days.
    Sign up for a free trial